Detalhe da pesquisa
1.
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.
Lancet Oncol
; 25(4): 463-473, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467131
2.
A Phase I study of the safety, pharmacokinetics and efficacy of navitoclax plus docetaxel in patients with advanced solid tumors.
Future Oncol
; 17(21): 2747-2758, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849298
3.
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies.
Br J Haematol
; 170(5): 669-78, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25942994
4.
A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors.
Invest New Drugs
; 32(5): 976-84, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24894650
5.
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors.
Invest New Drugs
; 32(5): 937-45, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916770
6.
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity.
Lancet Oncol
; 11(12): 1149-59, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21094089
7.
Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 24(18): 4371-4379, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29895707
8.
Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy.
Leuk Lymphoma
; : 1-4, 2023 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37626019
9.
Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
Curr Med Res Opin
; 22(9): 1839-47, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16968587
10.
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.
Cancer Discov
; 6(10): 1106-1117, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27520294
11.
Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Curr Med Res Opin
; 21(2): 245-54, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15801995
12.
Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study.
Curr Med Res Opin
; 21(1): 61-70, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15881476
13.
Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 76(5): 1025-32, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26420235
14.
Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with irinotecan: results of an open-label, phase 1 study.
Cancer Chemother Pharmacol
; 76(5): 1041-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26429709
15.
Comparison of five-day cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media.
Pediatr Infect Dis J
; 23(9): 834-8, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15361722
16.
Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
Clin Ther
; 26(12): 2026-33, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15823766
17.
A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
Clin Ther
; 24(4): 605-15, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12017405
18.
A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia.
Clin Ther
; 24(5): 736-51, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12075942
19.
Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients.
Curr Med Res Opin
; 19(5): 421-9, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-13678479
20.
Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Curr Med Res Opin
; 19(5): 411-20, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-13678478